NEW YORK (GenomeWeb) – Genomic Health reported after the close of the market Tuesday that its second quarter revenues were flat year over year, falling short of the consensus Wall Street estimate.

The Redwood City, California-based molecular diagnostics firm had total revenues of $70.6 million for the three months ended June 30, compared to $70.5 million in the second quarter of 2014. It fell short of the consensus Wall Street estimate of $71.7 million.

As in the first quarter, all of Genomic Health's revenues in the most recent quarter came from product sales.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more